Lone Star Bio



Filter News

Get news straight to your inbox by signing up for our free eNewsletters

Found 13,118 articles

  • DJO, LLC (“DJO” or the “Company”), a leading global provider of medical technologies to get and keep people moving, today announced the launch of the canal-sparing AltiVate® Anatomic CS EDGE™ Shoulder System. As the latest innovation from shoulder industry leader DJO®, the new system is designed to provide a more bone-sparing so

  • Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biopharmaceutical company focused on Alzheimer’s disease, today announced that clinical results of its Phase 2b study of sumifilam have been selected as a late-breaking oral presentation by the 13 th international conference on Clinical Trials on Alzheimer’s Disease (CTAD). CTAD is a prestigious annual conference focused on Alzheimer’s research and development and takes place this year as

  • Susan G. Komen®, the world’s leading breast cancer organization, recognized two widely respected and innovative breast cancer researchers this week, announcing that Donald McDonnell, Ph.D., and Laura Esserman, M.D., have been selected as this year’s recipients of the Brinker Awards – Komen’s highest scientific honor. Establish

  • StopAfib.org's annual "Get in Rhythm. Stay in Rhythm. ® Atrial Fibrillation Patient Conference" is for those living with atrial fibrillation (the most common irregular heartbeat, which increases stroke risk by 500%).   For the first time ever, the conference is virtual, which means anyone anywhere in the world has the good fortune

  • Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the closing of its initial public offering of 1,260,870 shares of its common stock at a public offering price of $5.75 per share for gross proceeds of $7,250,002, before deductin

  • bioAffinity Technologies , a privately held biotech company, today announced Martin Tammemägi , PhD, Professor Emeritus of Health Sciences at Brock University, will serve as Chairman of the bioAffinity Scientific and Medical Advisory (SMA) Board. “Dr. Tammemägi is exceptionally well respected and a leader in cancer epidemiology, lung cancer screening and cancer risk prediction modeling,” bioAffinity President and Chi

  • Allogeneic “off-the-shelf” chimeric antigen receptor-natural killer T cell (CAR-NKT) therapy platform could overcome many of the challenges of current autologous CAR-T therapies The CAR-NKT cell platform has tumor-homing properties and is unlikely to cause GvHD Phase 1 ANCHOR clinical study will enroll adult patients with relapsed/refractory (R/R) CD19 positive malignancies HOUSTON--( BUSINESS WIRE )-- Kuur Therapeutics, a leader i

  • Baylor College of Medicine and The Menninger Clinic jointly announce the hiring of Robert J. Boland , M.D., as vice chairman of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine and chief of staff at The Menninger Clinic. Boland joins the organizations on January 4, 2021 , after tran

  •  FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is pleased to announce it has entered into a manufacturing agreement with iBiologics to supply its proprietary allogeneic fibroblast ce

  • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual conferences. Conference Details: Jefferies Cell Therapy Virtual Summit Date/Time: Monday, October 5, 2020 at 11:30 a.m. EDT Format: Fireside chat 2020 Virtual Cell & Gene Meeting on the Mesa Date: Monday, October 12, 2020 – Friday, October

  • Taysha Makes Rapid Ascent from Launch to IPO

    Starting with $30 million in seed financing in April, Taysha sprinted through a $95 million Series B in August and rounded the corner this Thursday to bring in $157 million for its IPO.

  • CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today announced it has selected Image Analysis Group ("IAG") as the image partner for its upcoming Berubicin clinical tria

  •  Luminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary f

  • DisperSol Technologies LLC announced today that its Board of Directors has appointed David S. Snyder as its Chief Financial Officer effective October 1, 2020. “David Snyder is a highly accomplished pharmaceutical finance executive with extensive experience in managing the finances and growth of life science businesses,” said Dr. Edwar

  • Hanger, Inc. (NYSE: HNGR) (the "Company") today announced that Mark M. Jones, MD has been appointed to its Board of Directors, increasing the size of the Board to ten members, effective immediately. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200924005185/en/ Mark Jones, MD joins Hanger Board of Directors. (Photo: Business Wire) Dr. Jones curren

  • Taysha Gene Therapies, Inc. (“Taysha”), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations, today announced the pricing of its initial public offering of 7,869,566 shares of common stock at a price to the public of $20.00 per share. The shares are expecte

  • Project will expand utility of xMAP SARS-CoV-2 Multi-Antigen IgG Assay to better indicate whether individuals are protected against future infection   [23-September-2020]   AUSTIN, Texas , Sept. 23, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development Autho

  • CDISC is pleased to announce Dr. Maria Im Hee Shin of Daegu Catholic University Medical Center in South Korea has been named Chair of the Korea CDISC Coordinating Committee (K3C). CDISC Coordinating Committees (3Cs) support global CDISC initiatives within specific regions of the world and provide regional feedback to the central CDISC organization. “3Cs help strengthen relationships with international and local

  •  Pharm-Olam, a global mid-sized clinical research organization (CRO), has been selected by the U.S. Department of Defense (DOD) to build capability at military treatment facilities in order to support Phase III clinical trials of one or more lead COVID-19 vaccine candidates being developed under Operation Warp Speed . The CRO will prov

  •  Genesys Orthopedic Systems (the "Company"), a leading developer of medical implants and instruments for spinal fusion procedures, announced today that it has completed a senior credit facility with a regional commercial lender. By providing capital with the goal of growing its market share, the multimillion-dollar facility wil

Subscribe